Skin cancer mortality statistics

Deaths

Deaths from melanoma skin cancer, 2016, UK

 

Proportion of all deaths

Percentage melanoma skin cancer is of total cancer deaths, 2016, UK

 

Age

Peak rate of melanoma skin cancer deaths, 2014-2016, UK

 

Trend over time

Change in melanoma skin cancer mortality rates since the early 1970s, UK

Melanoma skin cancer is the 20th most common cause of cancer death in the UK, accounting for 1% of all cancer deaths (2016).[1-3]

In males in the UK, melanoma skin cancer is the 17th most common cause of cancer death (2% of all male cancer deaths). In females in the UK it is the 18th most common cause of cancer death (1% of all female cancer deaths).

59% of melanoma skin cancer deaths in the UK are in males, and 41% are in females.

Melanoma skin cancer mortality rates (European age-standardised (AS) rates Open a glossary item ) are similar to the UK average in all the UK constituent countries.

Melanoma Skin Cancer (C43), Number of Deaths, Crude and European Age-Standardised (AS) Mortality Rates per 100,000 Population, UK, 2016

  England Scotland Wales Northern Ireland UK
Male Deaths 1141 102 83 29 1355
Crude Rate 4.2 3.9 5.4 3.2 4.2
AS Rate 5.0 4.6 5.7 4.3 5.0
AS Rate - 95% LCL 4.7 3.7 4.5 2.7 4.7
AS Rate - 95% UCL 5.3 5.5 7.0 5.9 5.2
Female Deaths 796 60 56 18 930
Crude Rate 2.8 2.2 3.5 1.9 2.8
AS Rate 2.8 2.1 3.2 2.1 2.8
AS Rate - 95% LCL 2.6 1.6 2.4 1.2 2.6
AS Rate - 95% UCL 3.0 2.6 4.1 3.1 2.9
Persons Deaths 1937 162 139 47 2285
Crude Rate 3.5 3.0 4.5 2.5 3.5
AS Rate 3.8 3.2 4.4 3.1 3.7
AS Rate - 95% LCL 3.6 2.7 3.7 2.2 3.6
AS Rate - 95% UCL 3.9 3.7 5.1 3.9 3.9

95% LCL and 95% UCL are the 95% lower and upper confidence limits Open a glossary item around the AS Rate Open a glossary item

References

  1. Data were provided by the Office for National Statistics on request, October 2017. Similar data can be found here: http://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths.
  2. Data were provided by ISD Scotland on request, October 2017. Similar data can be found here: http://www.isdscotland.org/Health-Topics/Cancer/Publications/index.asp.
  3. Data were provided by the Northern Ireland Cancer Registry on request, December 2017. Similar data can be found here: http://www.qub.ac.uk/research-centres/nicr/.

About this data

Data is for UK, 2016, ICD-10 C43.

Last reviewed:

Melanoma skin cancer mortality is strongly related to age, with the highest mortality rates being in older people. In the UK in 2014-2016, on average each year almost half (45%) of deaths were in people aged 75 and over.[1-3] This largely reflects higher incidence and lower survival for melanoma skin cancer in older people.

Age-specific mortality rates rise steeply from around age 50-54 in males and 55-59 in females. The highest rates are in the 90+ age group for males and females.

Mortality rates are significantly higher in males than females in a number of (mainly older) age groups, The gap is widest at age 75 to 79, when the age-specific mortality rate is 2.1 times higher in males than females.

Melanoma Skin Cancer (C43), Average Number of Deaths per Year and Age-Specific Mortality Rates per 100,000 Population, UK, 2014-2016

95% LCL and 95% UCL are the 95% lower and upper confidence limits Open a glossary item around the AS Rate Open a glossary item

References

  1. Data were provided by the Office for National Statistics on request, October 2017. Similar data can be found here: http://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths.
  2. Data were provided by ISD Scotland on request, October 2017. Similar data can be found here: http://www.isdscotland.org/Health-Topics/Cancer/Publications/index.asp
  3. Data were provided by the Northern Ireland Cancer Registry on request, December 2017. Similar data can be found here: http://www.qub.ac.uk/research-centres/nicr/.

About this data

Data is for UK, 2014-2016, ICD-10 C43.

Last reviewed:

Melanoma skin cancer European age-standardised (AS) Open a glossary item mortality rates for males and females combined increased by 156% in the UK between 1971-1973 and 2014-2016.[1-3] The increase was larger in males than in females.

For males, melanoma skin cancer AS mortality rates in the UK increased by 247% between 1971-1973 and 2014-2016. For females, melanoma skin cancer AS mortality rates in the UK increased by 81% between 1971-1973 and 2014-2016.

Over the last decade in the UK (between 2004-2006 and 2014-2016), melanoma skin cancer AS mortality rates for males and females combined increased by 14%. In males AS mortality rates increased by 19%, and in females rates remained stable.

Melanoma Skin Cancer (C43), European Age-Standardised Mortality Rates per 100,000 Population, UK, 1971-2016

For most cancer types, mortality trends largely reflect incidence and survival trends. For example, rising mortality may reflect rising incidence and stable survival, while falling mortality may reflect rising incidence and rising survival.

Melanoma skin cancer mortality rates have increased overall in some broad age groups in males and females combined in the UK since the early 1970s, but have decreased or remained stable in others.[1-3] Rates in 0-24s have decreased by 70%, in 25-49s have remained stable, in 50-59s have increased by 53%, in 60-69s have increased by 177%, in 70-79s have increased by 282%, and in 80+s have increased by 430%.

Melanoma Skin Cancer (C43), European Age-Standardised Mortality Rates per 100,000 Population, By Age, UK, 1971-2016

References

  1. Data were provided by the Office for National Statistics on request, October 2017. Similar data can be found here: http://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths.
  2. Data were provided by ISD Scotland on request, October 2017. Similar data can be found here: http://www.isdscotland.org/Health-Topics/Cancer/Publications/index.asp.
  3. Data were provided by the Northern Ireland Cancer Registry on request, December 2017. Similar data can be found here: http://www.qub.ac.uk/research-centres/nicr/.

About this data

Data is for UK, 1971-2016, ICD-10 C43.

Last reviewed:

Melanoma skin cancer mortality rates are projected to fall by 15% in the UK between 2014 and 2035, to 4 deaths per 100,000 people by 2035.[1] This includes a smaller decrease for males than for females.

For males, melanoma skin cancer European age-standardised (AS) Open a glossary item mortality rates in the UK are projected to fall by 13% between 2014 and 2035, to 6 deaths per 100,000 by 2035.[1] For females, rates are projected to fall by 18% between 2014 and 2035, to 3 deaths per 100,000 by 2035.[1]

Melanoma skin cancer (C43), Observed and Projected Age-Standardised Mortality Rates, by Sex, UK, 1979-2035

 

It is projected that 3,210 deaths from melanoma skin (1,974 in males, 1,236 in females) will occur in the UK in 2035.

References

  1. Smittenaar CR, Petersen KA, Stewart K, Moitt N. Cancer Incidence and Mortality Projections in the UK Until 2035. Brit J Cancer 2016.

About this data

Data is for: UK, 1979-2014 (observed), 2015-2035 (projected), ICD-10 C43

Projections are based on observed incidence and mortality rates and therefore implicitly include changes in cancer risk factors, diagnosis and treatment. It is not possible to assess the statistical significance of changes between 2014 (observed) and 2035 (projected) figures. Confidence intervals are not calculated for the projected figures. Projections are by their nature uncertain because unexpected events in future could change the trend. It is not sensible to calculate a boundary of uncertainty around these already uncertain point estimates. Changes are described as 'increase' or 'decrease' if there is any difference between the point estimates.

More on projections methodology

Last reviewed:

There is evidence for an association between melanoma skin cancer mortality and deprivation in both males and females in England.[1] England-wide data for 2007-2011 show European age-standardised Open a glossary item mortality rates are 37% lower for males living in the most deprived areas compared with the least deprived, and 35% lower for females.[1] Melanoma skin cancer is one of the few cancers where mortality rates are lower for more deprived males and females compared to less deprived males and females.

Melanoma skin cancer (C43), European Age-Standardised Mortality Rates by Deprivation Quintile, England, 2007-2011

The estimated deprivation gradient in melanoma skin cancer mortality between people living in the most and least deprived areas in England has not changed in the period 2002-2011.[1] It is estimated that there would have been around 270 more deaths each year in England during 2007-2011 if all people experienced the same mortality rates as the least deprived.[1]

References

  1. Cancer Research UK and National Cancer Intelligence Network. Cancer by deprivation in England: Incidence, 1996-2010, Mortality, 1997-2011. London: NCIN; 2014.

About this data

Data is for: UK, 2007-2011, ICD-10 C43

Deprivation gradient statistics were calculated using mortality data for 2007-2011. The deprivation quintiles were calculated using the Income domain scores from the Index of Multiple Deprivation (IMD) from the following years: 2004, 2007 and 2010. Full details on the data and methodology can be found in the Cancer by Deprivation in England NCIN report.

Last reviewed:

Melanoma skin cancer is the 19th most common cause of cancer death in Europe, with around 22,200 deaths from melanoma skin cancer in 2012 (1% of the total). In Europe (2012), the highest World age-standardised Open a glossary item mortality rates for melanoma skin cancer are in Norway for men and Slovenia for women; the lowest rates are in Albania for men and Malta for women. UK melanoma skin cancer mortality rates are estimated to be the 19th highest in males in Europe, and 17th highest in females.[1] These data are broadly in line with Europe-specific data available elsewhere.[2]

There were around 55,500 deaths from melanoma skin cancer worldwide in 2012 (0.7% of total cancer deaths). Melanoma skin cancer mortality rates are highest in Australia/New Zealand and lowest in South Central Asia, but this partly reflects varying data quality worldwide.[1]

References

  1. Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available from: http://globocan.iarc.fr, accessed December 2013. 
  2. Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, et al.Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012. European Journal of Cancer (2013) 49, 1374-1403.

About this data

Data is for: Europe and Worldwide, 2012, ICD-10 C43

Last reviewed:

Cancer stats explained

See information and explanations on terminology used for statistics and reporting of cancer, and the methods used to calculate some of our statistics.

Citation

You are welcome to reuse this Cancer Research UK content for your own work.
Credit us as authors by referencing Cancer Research UK as the primary source. Suggested styles are:

Web content: Cancer Research UK, full URL of the page, Accessed [month] [year].
Publications: Cancer Research UK ([year of publication]), Name of publication, Cancer Research UK.
Graphics (when reused unaltered): Credit: Cancer Research UK.
Graphics (when recreated with differences): Based on a graphic created by Cancer Research UK.

When Cancer Research UK material is used for commercial reasons, we encourage a donation to our life-saving research.
Send a cheque payable to Cancer Research UK to: Cancer Research UK, Angel Building, 407 St John Street, London, EC1V 4AD or

Donate online

Acknowledgements

We are grateful to the many organisations across the UK which collect, analyse, and share the data which we use, and to the patients and public who consent for their data to be used. Find out more about the sources which are essential for our statistics.

Rate this page:

Currently rated: 2.3 out of 5 based on 22 votes
Thank you!
We've recently made some changes to the site, tell us what you think

Share this page